BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 1 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,818 | +10.0% | 28,856 | +25.3% | 0.00% | +33.3% |
| Q2 2023 | $378,098 | -10.7% | 23,027 | -9.2% | 0.00% | -25.0% |
| Q1 2023 | $423,573 | +130632.4% | 25,348 | +20.7% | 0.00% | – |
| Q4 2022 | $324 | -99.9% | 21,001 | +22.5% | 0.00% | -100.0% |
| Q3 2022 | $256,000 | -83.7% | 17,148 | -82.0% | 0.00% | -78.6% |
| Q2 2022 | $1,569,000 | -52.5% | 95,502 | -42.0% | 0.01% | -44.0% |
| Q1 2022 | $3,303,000 | -2.8% | 164,647 | +22.9% | 0.02% | 0.0% |
| Q4 2021 | $3,398,000 | -47.1% | 134,019 | -43.7% | 0.02% | -39.0% |
| Q3 2021 | $6,418,000 | +76.6% | 237,870 | +89.3% | 0.04% | +28.1% |
| Q2 2021 | $3,635,000 | +13.1% | 125,666 | +2.8% | 0.03% | +3.2% |
| Q1 2021 | $3,214,000 | +2961.0% | 122,217 | +2340.4% | 0.03% | +3000.0% |
| Q2 2020 | $105,000 | – | 5,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |